We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+16.1%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$1.69B
AUM Growth
+$3.51M
(+0.21%)
Cap. Flow
-$43.7M
Cap. Flow
% of AUM
-2.59%
Top 10 Holdings %
Top 10 Hldgs %
77.4%
Holding
50
New
6
Increased
5
Reduced
4
Closed
14
Top Buys
| 1 |
ITOS
iTeos Therapeutics
ITOS
|
+$86.1M |
| 2 |
Zymeworks
ZYME
|
+$68M |
| 3 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$23.6M |
| 4 |
Alkermes
ALKS
|
+$14.9M |
| 5 |
VRNA
Verona Pharma
VRNA
|
+$14.8M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
+$143M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$82.5M |
| 3 |
Oric Pharmaceuticals
ORIC
|
+$12.1M |
| 4 |
Beam Therapeutics
BEAM
|
+$10.3M |
| 5 |
Ginkgo Bioworks
DNA
|
+$8.34M |
Sector Composition
| 1 | Healthcare | 99.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zymeworks
ZYME
$1.82B
| $288M | 17.08% |
22,970,388
+5,710,840
| +33% | +$68M |
|
|
APLS
2
DELISTED
Apellis Pharmaceuticals
APLS
| $206M | 12.2% |
11,895,808
| – | – |
|
3
Jazz Pharmaceuticals
JAZZ
$15.1B
| $181M | 10.73% |
1,706,469
| – | – |
|
4
AnaptysBio
ANAB
$1.67B
| $175M | 10.37% |
7,880,094
| – | – |
|
5
Crinetics Pharmaceuticals
CRNX
$8.88B
| $123M | 7.31% |
4,288,120
| – | – |
|
|
ITOS
6
DELISTED
iTeos Therapeutics
ITOS
| $107M | 6.32% |
+10,688,978
| New | +$86.1M |
|
7
CRISPR Therapeutics
CRSP
$5.03B
| $67.6M | 4% |
1,389,276
| – | – |
|
8
uniQure
QURE
$2.81B
| $55.6M | 3.3% |
3,988,971
| – | – |
|
9
Tango Therapeutics
TNGX
$4.95B
| $54.4M | 3.23% |
10,630,736
| – | – |
|
10
Xencor
XNCR
$1.11B
| $48.3M | 2.86% |
6,144,767
| – | – |
|
11
Immunome
IMNM
$2.58B
| $37.9M | 2.25% |
4,079,415
| – | – |
|
12
Janux Therapeutics
JANX
$969M
| $34M | 2.01% |
1,469,818
| – | – |
|
|
LKFT
13
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $29M | 1.72% |
1,036,945
+881,939
| +569% | +$23.6M |
|
14
Eton Pharmaceutcials
ETON
$1.04B
| $28.9M | 1.71% |
2,030,544
+91,256
| +5% | +$1.44M |
|
15
Kura Oncology
KURA
$1B
| $24.2M | 1.44% |
4,200,000
+1,559,702
| +59% | +$9.56M |
|
|
AKRO
16
DELISTED
Akero Therapeutics
AKRO
| $23.5M | 1.39% |
440,000
| – | – |
|
17
Madrigal Pharmaceuticals
MDGL
$12.7B
| $22.7M | 1.35% |
75,000
| – | – |
|
18
Neurogene
NGNE
$794M
| $19M | 1.13% |
1,271,342
| – | – |
|
|
VRNA
19
DELISTED
Verona Pharma
VRNA
| $18.9M | 1.12% |
+200,000
| New | +$14.8M |
|
|
TECX
20
Tectonic Therapeutic
TECX
$609M
| $18.6M | 1.1% |
935,121
| – | – |
|
|
21
Oric Pharmaceuticals
ORIC
$1.16B
| $16.4M | 0.97% |
1,618,068
-1,800,000
| -53% | -$12.1M |
|
|
22
Alkermes
ALKS
$8.68B
| $14.3M | 0.85% |
+500,000
| New | +$14.9M |
|
|
RNAM
23
DELISTED
Avidity Biosciences
RNAM
| $14.2M | 0.84% |
500,000
-57,576
| -10% | -$1.72M |
|
|
MBX
24
MBX Biosciences
MBX
$2.84B
| $13.1M | 0.78% |
1,149,794
-109,479
| -9% | -$1.12M |
|
25
Voyager Therapeutics
VYGR
$193M
| $12.2M | 0.72% |
3,917,546
| – | – |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM